Depresszió: vizsgálatok itt: Horvátország
2 of 3 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleLong-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Grad Zagreb
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06966401 · EU 2024-519423-24-00 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Grad Zagreb
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06786624 · EU 2024-519418-29-00